Faculty

Adjunct Assistant Professor Bryan Ang is the Deputy Head of the Glaucoma Service and Head of Clinical Services, at the National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.

Dr Ang was awarded Distinction in Surgery and 2nd Best Candidate in Surgery in the Final M.B.B.S at the National University of Singapore, and was further awarded the Gold Medal in the Masters in Medicine Ophthalmology examinations.

Dr Ang’s clinical and research interest is in Minimally Invasive Glaucoma Surgery (MIGS). His surgical techniques in MIGS have won multiple surgical film awards, including 1st Prize (2023) and 2nd Prize (2019) at the World Glaucoma Congress, and Best Video (2021) at the American Academy of Ophthalmology Annual Meeting. To date, Dr Ang has published more than 60 scientific papers in international journals and holds several research grants focusing on glaucoma surgery and diagnostics.

He is an appointed International Research Collaborator with the Mayo Clinic, USA, sits on the editorial boards of several journals, and is regularly invited as speaker and course faculty for glaucoma at international conferences, including the Asia-Pacific Glaucoma Congress, Asia-Pacific Academy of Ophthalmology Annual Meeting, American Society for Cataract and Refractive Surgeons Annual Meeting, World Ophthalmology Congress and the World Glaucoma Congress.

Dr Ang is also currently a member of the National Glaucoma Subspecialty Committee, College of Ophthalmologists, Singapore, and is the immediate-past Treasurer of the Glaucoma Association of Singapore.

MBBS (Singapore), FRCS(Ed), FRCOphth (UK), MMed (Ophth) (Singapore), FAM (Singapore), PhD (London)

Professor Aung is currently:

1. Chief Executive Officer, Singapore National Eye Centre
2. Academic Chair, Ophthalmology and Visual Sciences Academic Clinical Program (EYE ACP), Duke-NUS Medical School
3. ‘Kwan Im Thong Hood Cho Temple’ Distinguished Professor of Ophthalmology, Duke-NUS Medical School
4. Associate Dean, Office of Research, Duke-NUS Medical School
5. Senior Consultant, Glaucoma Department, Singapore National Eye Centre
6. Principal Investigator and Chairman of Board, Singapore Eye Research Institute
7. Group Director, Research (Scientific), SingHealth

Having obtained his MBBS from the National University of Singapore, Prof Aung obtained the Fellowships of the Royal College of Surgeons of Edinburgh and the Royal College of Ophthalmologists in 1997. He completed a glaucoma fellowship in the Singapore National Eye Centre from 1999-2000, and from 2000-2003, he trained at the Institute of Ophthalmology, University College London and Moorfields Eye Hospital; and was awarded a PhD in Molecular Genetics from University College London in 2004.

Professor Aung is a clinician scientist, with clinical practice focusing on glaucoma and research interests in angle closure glaucoma and glaucoma genetics.

Professor Aung’s research has secured more than SGD40 million in competitive research grant funding. He is currently the Lead PI of the Large Collaborative Grant (LCG), “Tackling and Reducing Glaucoma Blindness with Emerging Technologies (TARGET), a $25 million multi-disciplinary and multicenter program grant awarded by the National Medical Research Council, Singapore in 2022. Prof Aung was awarded the Singapore Translational Research (STaR) Investigator Award in 2014 and 2020 and many international awards including the Nakajima Award (2007) and De Campo Award (2013) by the Asia Pacific Academy of Ophthalmology, the Alcon Research Institute Award (2013), the Robert Ritch Award for Excellence and Innovation in Ophthalmology by the Glaucoma Foundation (2017), as well as numerous other awards/medals.

Professor Aung currently has more than 700 publications (h-index 104) including 15 major papers in Nature Genetics, JAMA and Lancet. He has delivered more than 300 Invited Lectures at many international meetings. He is on the Editorial Board of 7 journals (including Ophthalmology, Progress in Retinal and Eye Research, Ophthalmology Glaucoma, Eye and Graefe’s Archive for Clinical Exp Ophthalmology; and a regular reviewer for more than 15 journals.

Professor Aung currently serves as the Vice-President of the Asia Pacific Glaucoma Society. He was President of the World Glaucoma Association from 2016-2017, President of the College of Ophthalmologists of Singapore from 2012-2014 and President of the Singapore Society of Ophthalmology from 2009-2011.

Professor Aung is actively involved in medical education of undergraduates and post graduates. He supervises and mentors PhD students, Clinical and Research Fellows, and medical students, especially in the areas of glaucoma and translational research.

Keith is a Glaucoma Specialist at Moorfields, Professor of Ophthalmology in UCL and surgical innovator who has pioneered treatments in the commercially unattractive area of surgical intervention in advanced and complex glaucomas as well as MIGS. He is known throughout the world for surgery, has been instrumental in landmark trials that have defined the evidence base for glaucoma drainage devices and refined that for lasers and trabeculectomy, including TVT, ABC, PTVT, TAGS and LIGHT. He co-designed the Paul Glaucoma Implant and has dedicated his career to refining GDD implantation to achieve physiological IOP control early after surgery.

Keith has been BJO Editor-in-Chief, Chair of Glaucoma UK (charity), Director of Moorfields’ Clinical Glaucoma Service and Hong Leong Visiting Professor at National University of Singapore. Awarded the Charamis Medal for achievement in surgery and the International Scholar Award of the American Glaucoma Society, he is also Treasurer of ISGS, founder of ESCRS Glaucoma Day and founded and continues to organise the annual Moorfields International Glaucoma Symposium. He co-founded and runs Ophthalmology Futures Forums providing a platform for innovative startups to pitch to corporate leaders and financiers in an environment directed by clinicians, which last year celebrated its 10th year. He has been in “The Ophthalmologist” Power List 4 times (no. 10 in 2018).

Dr Poemen CHAN graduated from The University of Hong Kong with multiple scholarships and awards, including CP Fong Gold Medal in Medicine, H.C. Liu Prizes in Anatomy, Mr & Mrs S. H. Wong Foundation Scholarship, BL Wong Scholarships and Yu Chun Keung Mem. Scholarships. He started ophthalmology training in Hong Kong Eye Hospital in 2007 and was promoted associate consultant in 2014. He granted the HC Ho Medical Education Foundation Scholarship in 2015 for his overseas clinical visit in Moorfield′s Eye Hospital (London, UK) and Prism′s Eye Institute (Toronto, Canada). During the service, he received the Best Poster Display Award in the Hospital Authority Convention 2014, Outstanding Staff and Team Award in Hospital Authority Convention 2016 and The Best Service Provider award of Hong Kong Eye Hospital. Since he joined the Department, he was awarded ″Distinguished Young Fellow of the Hong Kong Academy of Medicine (2021)″, ″Overall Gold Award″ and the ″Best Self-initiated Project Award″ from the Academy of Asia-Pacific Professors of Ophthalmology Academic Development Mentorship Scheme (AAPPO-ADMS) (2023). His paper on the ten-year outcome of acute primary angle closure was also selected as ″Paper of the month″ by the Associate Advisory Board of the World Glaucoma Association. To date, he has published >45 papers in index journals, and >10 textbook chapters. In academic conferences, he delivered >35 invited lectures, >60 conference papers, and >10 instruction courses. He obtained >$HKD 6 million research grants (including fundings from Research Grants council and Health and Medical Research Funds) and >$HKD 2 million UGC-supported teaching grants.Dr Chan is currently the coordinator of the CUHK-HKEH-PWH International Fellowship Programme, the programme director of glaucoma surgery subspecialty for the CUHK Jockey Club Ophthalmic Microsurgical Training Programme, the Academic Coordinator of the glaucoma service of Hong Kong Eye Hospital. He is the Associate Head of the Undergraduate Division, as well as responsible for undergraduate teaching that involved flipped classroom teaching and online e-learning.

Internationally, he was an invited participant of the World Glaucoma Association (WGA) Consensus Meeting XI in 2019. He served as glaucoma subspecialty liaison for the World Ophthalmology Congress (WOC) 2018, Secretary and coordinator of the glaucoma subspecialty for the 33rd, 34th, 36th, and 38th Asia-Pacific Academy of Ophthalmology (APAO) Congress in 2018, 2019, 2021, and 2023. He is an invited member of the Associate Advisory Board and the Global Outreach Committee of WGA. He is also an invited committee member of the Associated board of Asia Pacific Glaucoma Society (APGS).

Jonathan is a clinician-scientist and Professor of Ophthalmology at the University of Sydney and Glaucoma Consultant at Eye Associates and the Royal Prince Alfred Hospital. His research focuses on understanding the impact of ageing on the optic nerve and related diseases with a view to developing new therapeutic approaches for protecting the optic nerve. His expertise spans experimental and clinical research. He is passionate about medical education, lecturing and mentorship.

He obtained his medical degree at the Royal Free Hospital School of Medicine, London, and a PhD at University College London. Following ophthalmology training at Moorfields Eye Hospital, he completed glaucoma fellowships at Westmead Hospital in Sydney and the University of California, San Diego. He was subsequently appointed to the UCSD Faculty and served as Director of the Hamilton Glaucoma Center Basic Research Laboratories. He was subsequently appointed as Head of Ophthalmology at the University of Melbourne and Director of CERA for 10 years prior to moving to Duke-NUS in Singapore to help established the Centre for Vision Research. He returned to Australia late 2022 and holds an Adjunct Professor of Ophthalmology at Duke-NUS Medical School.

• Consultant Ophthalmologist at the Glaucoma Center, Swiss Visio, Montchoisi Clinic, Lausanne
• Adjunct Professor of Ophthalmology at the University of Colorado, Denver
  – Executive Vice President of the World Glaucoma Association
• Co-founder and President of the Swiss Glaucoma Research Foundation

Dr Mansouri is a glaucoma specialist and a clinician-scientist. His academic accomplishments include over 200 peer-reviewed journal articles with an h-index of 86 (google scholar).

He has been ranked as the N. 2 glaucoma researcher worldwide between 2020 -2025 by ScholarGPS (June 2025). Since 2020, he has been continually ranked as one of the Top 20 Glaucoma Specialists in the world (Expertscape.com).

Dr Mansouri’s clinical and scientific expertise has resulted in him being selected by the journal “The Ophthalmologist” as a Top 100 Ophthalmologist in the world (Power List 2024). Previously, he had been ranked twice in the top 40 under 40 power list by the journal “The Ophthalmologist”. He has also been chosen as a top ophthalmic innovator by the journal CRST Europe (Nov 2022).

In 2012, Dr Mansouri was the first ophthalmologist to give a TEDx talk, with the aim of improving glaucoma awareness. He has been featured on BBC World (“Secrets of the Superagers/Senses”).

He directs an active fellowship program which trains candidates from all continents and is a host to ICO fellows from developing countries.

Dr Mansouri has been the recipient of several international awards, including the prestigious Boberg-Ans from the Danish Ophthalmological Society, the MGS Alcon International Lecture, the American Academy of Ophthalmology (AAO) Achievement Award and AAO International Scholar Award, among others. He has given several keynote lectures, among them the 1st Stefano Gandolfi Lecture of the Italian Glaucoma Society (June 2025).

He is on the editorial boards of the “Journal of Glaucoma” and the “Revista Brasileira de Oftalmologia”, is an associate editor of “Acta Ophthalmologica”, and is a contributing editor to the “International Glaucoma Review”. He is co-editor of the textbook “The Science of Glaucoma Management” and co-author of 12 textbook chapters.

Dr. Kaweh Mansouri is a pioneer and expert in the use of intraocular pressure monitoring technology and a pioneer in MIGS. His research activities are focused on advancing 24-h IOP monitoring, as well as the development of new technologies in the field of glaucoma imaging and surgery.

He is also the former Chief Medical Officer of iStar Medical, Belgium, Implandata GmbH, Germany, and Sensimed AG, Switzerland.

Ringland Anderson Professor and Head of Ophthalmology, University of Melbourne
Managing Director, Centre for Eye Research Australia
Director of Research (Victoria), Australian Vision ResearchKeith Martin is Director of the Centre for Eye Research Australia and Ringland Anderson Professor and Head of Ophthalmology at the University of Melbourne. Until January 2019, he was Professor and Head of Ophthalmology at the University of Cambridge, and Deputy Director of the University’s John van Geest Centre for Brain Repair. He was also Clinical Director for Ophthalmology at Cambridge University Hospital.Professor Martin is working to develop new treatments for eye disease using gene therapy and other techniques. His other current main research interest is in regeneration and repair of the optic nerve.

He is co-founder of Quethera, a Cambridge-based gene therapy company which developed a gene therapy for glaucoma that is currently in advanced pre-clinical development with Astellas Inc, and Ikarovec, a second gene therapy spin out company from his Cambridge lab developing gene therapies for common retinal diseases. He is also a founding Director of three further spin out companies from the Centre for Eye Research Australia: Mirugen, developing cell reprogramming technology for inherited retinal diseases; Enlighten Imaging, developing hyperspectral imaging technology for the diagnosis of retinal and neurological diseases; and Cerulea Clinical Trials, a new state-of-the-art ophthalmic clinical trials facility that recently received a $10m investment from the Victorian Government.

Clinically, Professor Martin specialises in the medical and surgical management of complex glaucoma. He was President of the World Glaucoma Association from 2018-20, is a Past President of the UK and Ireland Glaucoma Society, and is currently Chair of the Australia and New Zealand Glaucoma Society.

Professor, MD, PhD

Soeul National University
Department: Ophthalmology

Ki Ho Park is a professor of ophthalmology at Seoul National University and the President of the Glaucoma Research Society (GRS), President of the Korean Myopia Society (KMS), Vice-President of Asia Pacific Ocular Imaging Society (APOIS) and Asian Angle Closure Glaucoma Club (AACGC) and Board Member of International Council of Ophthalmology (ICO).

He is Associate editor of Journal of Glaucoma and International Glaucoma Review (IGR); Section editor of the British Journal of Ophthalmology, Asia Pacific Journal of Ophthalmology, and Japanese Journal of Ophthalmology; and Editorial board member of IOVS, Scientific Reports, and Korean Journal of Ophthalmology.

He has been served as the past president of the Asia Pacific Glaucoma Society (APGS) and Korean Ophthalmological Society (KOS), Korean Glaucoma Society (KGS) and the past Board of Governors of the World Glaucoma Association (WGA).

He has published more than 400 papers in SCI journals, 14 book chapters, and more than 200 international lectures including AAO Glaucoma Subspecialty Day Lecture in 2013 and 2019 and a lecture in American Glaucoma Society Annual meeting in 2022 and a Keynote Lecture in Japanese Clinical Ophthalmology Society Meeting in 2015 and the first ‘Masterclass Lecture’ in APGS webinar Series in 2021.

He was awarded the AAO Senior Achievement Award and APAO Senior Achievement Award and APGS Asia Pacific Award.

MD, Associate Professor, Department of Ophthalmology, Faculty of
Medicine, Chulalongkorn University, Bangkok Thailand.

Current appointments
President: Thai Glaucoma Society (ThGS);
Deputy Secretary General & Newsletter editor: Asia Pacific Glaucoma Society (APGS);
Head of Center of Excellence in Glaucoma: Chulalongkorn;
University Chief of Administrative Officers (CAO), Senior Instructor and consultant: Department of
Ophthalmology, Faculty of Medicine, Chulalongkorn University, (MDCU), Bangkok, Thailand;
Sub-committee of academic affairs: The Royal College of Ophthalmologists of Thailand (RCOPT);
Private Consultant: MedPark hospital, St Louis General Hospital;

Education
Medical Degree with honours from Chulalongkorn University, Bangkok, Thailand;
Diploma in Ophthalmology & Glaucoma Fellowship training at King Chulalongkorn Memorial Hospital;
Certificate in Clinical Glaucoma Fellowship from The Royal Victorian Eye and Ear Hospital, Centre for Eye Research Australia (CERA), University of Melbourne, Australia;

Awards

• The Asia Pacific Academy of Ophthalmology (APAO) Achievement Award in 2023.
• The Personnel of the year Award from Chulalongkorn University in 2024.
• The Honorary Award 2024 from Faculty of Medicine, Chulalongkorn University to the person who
  brings the reputation and pride to the faculty.

Academic experiences
A regular invited reviewer for several peer-reviewed journals in Ophthalmology.
Having been doing, mentoring, and participating in glaucoma diagnosis and therapeutic research both locally and internationally.
Under her advisement, one of the advisees was granted Prince Mahidol Youth Award, the renowned prestigious fund for medical student project.
Being entrusted to lead the organizing team of numerous national and international scientific meetings in which acclaimed at high success as well as being regularly invited to speak and chair sessions in various national and international scientific conferences.

Educational conference and scientific congress organizer

•  Founder: Interhospital Glaucoma Conference for Thai Glaucoma Society 2013-present
• Chairman and Advisor: Soft Cadaver Glaucoma Workshop 2015-present
• Secretary General: Thailand Glaucoma Camp 2015-2019
• General Secretary: Asia Pacific Glaucoma Congress (APGC) 2016 2015-2016
• Organizing Chairman: Regional Glaucoma Grand Rounds 2021-present
• Vice Congress Secretary: APACRS 2026 2025-2026

Professor Clement C.Y. THAM is the Chairman of the Department of Ophthalmology and Visual Sciences at The Chinese University of Hong Kong (CUHK), S.H. Ho Professor of Ophthalmology and Visual Sciences at CUHK, and the Director of CUHK Eye Centre.

Internationally, Prof Tham is the President of the Asia-Pacific Glaucoma Society (APGS), the largest supranational glaucoma professional society in the Asia-Pacific region. The APGS hosts the Asia-Pacific Glaucoma Congress (APGC) biennially in the Asia-Pacific region, which is the largest clinical and scientific glaucoma conference in our region.

Prof Tham is the Secretary-General and CEO of the Asia-Pacific Academy of Ophthalmology (APAO), which comprises 39 national ophthalmic member societies and regional subspecialty member societies. Membership of APAO member societies totals over 120,000 ophthalmologists, which is around 59% of the total number of ophthalmologists in the world.

Prof Tham is also the Founding President of the Hong Kong Glaucoma Society (HKGS), and the Vice President (Education and Examinations) of the Hong Kong Academy of Medicine.

Prof Tham is the Past President of the College of Ophthalmologists of Hong Kong (COHK), and the Immediate Past Treasurer of the International Council of Ophthalmology (ICO).

Prof Tham was recognized by Expertscape′s PubMed-based algorithms as the top 1% of scholars writing on Glaucoma in the previous 10 years. He was voted to become a member of, ‵The Ophthalmologist Power List – Top 100 Most Influential Ophthalmologists′ in 2022, 2023, and 2024, the “Top 10” of “Asia-Pacific Eye 100” in 2023 and 2025, and the “World Eye-Cons-21” of the Asia-Pacific Journal of Ophthalmology (APJO) in 2024 and 2025. Prof Tham has also received numerous other international awards in recognition of his contributions to research and teaching in ophthalmology.

BSc(Hons), MBBS, FRCSEd, FRCOphth, PhD (Lond), FAMS

Professor Tina Wong is a senior consultant (and immediate past Head) in the Glaucoma Service at the Singapore National Eye Centre, and the current Vice Chair in Faculty and Professional Development for Ophthalmology at Duke NUS. She is also the Director of Clinical Translational Research and co-Head of the Ocular Therapeutics and Drug Delivery Group at the Singapore Eye Research Institute. Professor Wong has a specialist interest in ocular scarring and post glaucoma surgery management. She leads an inter-disciplinary research programme on translational and clinical research on developing new therapeutics as well as drug repurposing and sustained drug delivery systems aimed at improving patient adherence. Her research has improved the understanding of the burden and risk factors that affect the surgical outcomes of glaucoma surgery. She has established a validated animal model to interrogate the post surgical wound healing response as has published a roadmap for new therapeutic drug development from the lab to clinical.

Professor Wong developed 2 sustained drug delivery therapies, reaching Ph2 clinical trials for the medical treatment of glaucoma and cataract surgery. She holds 10 patents to her name and is a co-founder of 3 spin off biotech companies generated from her research. Professor Wong is a scientific thought leader in the field of wound healing in glaucoma surgery and sustained delivery of therapeutics.

Professor Wong has received national and international awards for her contribution to the field of glaucoma surgical wound healing and sustained ocular therapeutics delivery. Of notable mention, Professor Wong was awarded the President’s Science and Technology Award in Singapore in 2014. This award is the country’s highest honour bestowed on exceptional research scientists and engineers in Singapore for their excellent achievements in science and technology. These national awards are given annually to recognise and celebrate outstanding and invaluable contributions by individuals or teams to the research and development landscape in Singapore. This research was recognized as one of the top 50 significant developments in Singapore in past 50 years in the same year.

Professor Wong has an eminent standing in the international glaucoma community. She is a well-recognized world authority on glaucoma and ocular wound healing and has delivered over 40 plenary and invited talks to date. She listed in the Ophthalmologist Power List, 2023, the Asia Pacific Eye 100 – 100 most influential ophthalmologists 2022 and 2025, and recipient of Outstanding Service for the Prevention of Blindness Award, APAO. She is a member of the prestigious Glaucoma Research Society (only top 100 clinicians and clinician scientists are members in the world). Professor Wong is the scientific chair for the Asia Pacific Glaucoma Congress, 2026. She is the Founding President of the Glaucoma Association Singapore and serves on advisory boards for several ophthalmic pharmaceutical and medical device companies.

Hao F. Zhang is a Professor of Biomedical Engineering and Ophthalmology (by courtesy) at Northwestern University.

He received his BS and MS degrees from Shanghai JiaoTong University (Shanghai, China) in 1997 and 2000, respectively, and his Ph.D. degree from Texas A&M University (College Station, Texas) in 2006. From 2006 to 2007, he was a post-doctoral fellow at Washington University in St. Louis. He and colleagues reported the first demonstration of photoacoustic microscopy (Nature Biotechnology 2006, Nature Protocols 2007, PNAS 2010, Nature Communications 2019), spectroscopic super-resolution imaging (Nature Communications 2016, PNAS 2016, Optica 2019, Light: Science and Applications 2020, Nanophotonics 2022, NanoLetters 2023), visible-light optical coherence tomography (Light: Science and Applications 2016, J. Neuroscience 2022, PNAS 2022, IEEE TMI 2024, 2025).

He received the NSF CAREER award and NIH Director’s Challenge Award in 2010, the NIH IMPACT award in 2015, the SPIE Translational Research Award in 2016, and the US National Academy of Sciences Cozzarelli Prize in 2017. He is a fellow of Optica and the American Institute for Medical and Biological Engineering.

His research interests include optical coherence tomography, super-resolution imaging, ophthalmology and vision science, and genomics. In 2015, he co-founded Opticent Health to commercialize visible-light optical coherence tomography. In 2023, he founded the Center of Engineering for Vision and Ophthalmology (CEVO) at Northwestern University. For more information, please visit
http://foil.northwestern.edu.

• Professor of Ophthalmology at Zhongshan Ophthalmic Center (ZOC) , Sun Yet-sen University, China
• TOP 100 most influential people in ophthalmology in the Ophthalmologist Power List (2023, 2014)
• TOP 100 most influential people in ophthalmology in the Asia-Pacific region (2025, 2023)
• Top 30 and 50 Expertise in Glaucoma Worldwide in Expertscape (2020-2024)
• Active member of Glaucoma Research Society (GRS)
• Fellow of the Academy of Asia-Pacific Professor of Ophthalmology (AAPPO)
• Vice president of the Asia-Pacific Ocular Imaging Society (APOIS)
• Board member of the Asia-Pacific Glaucoma Society (APGS)
• Board member of International AI in Ophthalmology Society (IAIOph)
• Convener of the Glaucoma Scientific Program of Asia-Pacific Academy of Ophthalmology (APAO 2026,2025,2024,2019 and 2018)
• The Outstanding Service in Prevention of Blindness Awards of APAO
  (2025）
• The Senior Achievement Award of APAO (2025)
• The Molteno Lecture Award of APGS (2024)
• The Distinguished Service Award of APAO 2021
• The Prestigious Achievement Award of Ophthalmic Image Analysis in 2019
• The Achievement Award of APAO in 2017
• Published 219 SCI articles, Cite Index 8220（Google), H Index 51 (Google Scholar), IF＞10 has 24
• Published four self-authored books
  • Illustrated Surgical Techniques and Pearls of MIGS (2022)
  • Illustrated anterior segment examinations and diagnosis of glaucoma(2020)
  • Illustrated surgical techniques and pearls of glaucoma(2016)
  • Illustrated clinical diagnosis and treatment of glaucoma(2014)
• Published ten books of translated versions of The WGA Consensus Series and The Asia-Pacific Glaucoma Guideline